Ipamorelin and CJC-1295 are usually discussed together because most self-experimenters run them as a stack. They target different receptors but converge on the same downstream effect: stimulating endogenous growth hormone release. Tracking the combination has its own rules.
How they differ
- Ipamorelin — ghrelin mimetic, short-acting, stimulates GH pulses without significantly affecting cortisol or prolactin
- CJC-1295 (no DAC) — GHRH analog, short-acting (Mod GRF 1-29 / DAC-free version)
- CJC-1295 (with DAC) — long-acting version, half-life measured in days
The "ipa + CJC no DAC" stack is the most common: dosed together so the two mechanisms hit at the same time.
Typical protocol shape
A common (not prescriptive) shape:
- Frequency: 1–3 times daily SC
- Timing: empty stomach, often pre-bed and post-workout
- Cycle length: 8–12 weeks
- Wash-out: 4+ weeks
The "empty stomach" rule comes from the observation that meals (particularly with sugar/fat) blunt the GH pulse. Most protocols specify ~2h after the last meal and ~30 min before the next.
What to track daily
- Dose log (count, timing relative to meals and sleep)
- Sleep quality
- Subjective fatigue / energy
- Hunger (some users report increased appetite with ghrelin mimetics)
- Any flushing or head-rush sensation at injection time (common, transient)
What to track weekly
- Body weight, body composition if you have access (calipers, DEXA, smart scale trend)
- Waist circumference
- Workout performance (working sets and reps at the same weight)
- Sleep summary (cycles, deep sleep if tracked)
What to test in bloodwork
- IGF-1 — the most direct downstream marker of effective GH stimulation
- Fasting glucose and HbA1c — GH and GH-releasing peptides can affect glucose
- Lipid panel
- Cortisol — if you switch to a non-selective GHRP (e.g. GHRP-6), this matters more than with ipamorelin
A pre/mid/post panel is informative; a pre/post-only panel is still better than nothing.
Common patterns and findings in self-reports
- Sleep quality changes are the most common subjective effect
- Body composition changes are gradual and require 8+ weeks to evaluate
- Strength changes are typically small in trained populations
- Recovery improvements are widely reported, harder to isolate from sleep effects
Common mistakes
- Meals near doses — the most common reason a protocol "doesn't work"
- Inconsistent timing — GH release follows pulses; random timing kills the rhythm
- No IGF-1 labs — you cannot evaluate this stack without it
- Stacking too many things — if you also start creatine, change your diet, and start sleeping more, the peptide's effect becomes unattributable
A worked tracking template
Goal: improve sleep quality and recovery during a hypertrophy block.
- Stack: ipamorelin 200 mcg + CJC-1295 (no DAC) 100 mcg, twice daily SC (post-workout + pre-bed)
- Duration: 10 weeks
- Pre/post IGF-1, fasting glucose, HbA1c, lipid panel
- Daily log: doses, meal timing, sleep score
- Weekly log: training PRs, weight, waist
- Photos every two weeks
That is enough structure that, at the end of 10 weeks, you have something to look at.
A note on DAC vs no-DAC
Long-acting CJC-1295 (with DAC) flattens out the pulse pattern by maintaining elevated GHRH activity. Some users prefer this for the convenience; others argue the flatness is exactly what you don't want, since natural GH release is pulsatile. There is no consensus. If you try both, track them as separate cycles — not as a transition mid-protocol.
Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.